Skip to content
NeuroDeRisk
NeuroDeRisk
Neurotoxicity De-Risking in Preclinical Drug Discovery
  • Home
  • Consortium
    • Consortium Partners
    • Scientific Advisory Board
  • Neurotoxicity
  • in silico Toolbox
  • News
  • Q & A
  • Contact
  • Search
  • Home
  • Consortium
    • Consortium Partners
    • Scientific Advisory Board
  • Neurotoxicity
  • in silico Toolbox
  • News
  • Q & A
  • Contact
  • Search

Tag: WP4

Press Release: NeuroDeRisk – Cracking the code of neurotoxicity
First Year Anniversary Meeting held online
WP 4 – Coordination Meeting

WP 4 – Coordination Meeting

March 6, 2020 April 29, 2022

Monday, February 24, 2020 – Tuesday, February 25, 2020, Vienna, Austria. Colleagues from the NeuroDeRisk consortium working on Work Package 4 met in Vienna to discuss the in silico NeuroDeRisk …

 Coordination Meeting | NeuroDeRisk | University of Vienna | WP4
Read more"WP 4 – Coordination Meeting"

Academic Project Coordinator

Thierry Langer, University of Vienna

EFPIA – Project Leader

Jacques Richard, Sanofi

Join NeuroDeRisk.EU on

 

The NeuroDeRisk project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 821528.
This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.

Innovative Medicines Initiative
European Union
EFPIA
  • Imprint-
  • Disclaimer-
  • Privacy Policy-
Back to Top

© NeuroDeRisk